ReviewDiabetes/metabolism research and reviews2026
A Novel Paradigm for Adult-Onset Type 1 Diabetes: Once-Weekly Basal Insulin and SGLT-2 Inhibition to Harness Residual β-Cell Function.
Paolo Pozzilli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.